Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo

doi:10.3748/wjg.v11.i7.1060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2744)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

311

HTML

2270

Figures (1-5)

163

Sum=2744

Feb 21, 2005 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 21, 2005; 11(7): 1060-1064
Published online Feb 21, 2005. doi: 10.3748/wjg.v11.i7.1060

Full Size Figure Download Figure

Figure 1 mdr1 mRNA expression of tumors from three patients. Lane 1: DNA marker, lane 2: positive control, lane 3: negative control, lane 4: patient III, lane 5: patient I, lane 6: patient II.

Citation: Shen LZ, Hua YB, Yu XM, Xu Q, Chen T, Wang JH, Wu WX. Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo. World J Gastroenterol 2005; 11(7): 1060-1064
URL: https://www.wjgnet.com/1007-9327/full/v11/i7/1060.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i7.1060